CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al > Summary
Court Case Number 2:18-cv-16035
Filing Date Nov 9, 2018
Termination Date Feb 7, 2019
Court New Jersey District Court
Status Statistical Closing
JudgesEsther Salas, Michael A. Hammer
Plaintiff
Defendant
Plaintiff Attorneys
13Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Celgene
Attorney Name: Cary Miller
Jones Day
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Celgene
Attorney Name: Evangeline L. Shih
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Gabriel P. Brier
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Marta A. Godecki
Quinn Emanuel Urquhart & Sullivan
Defendant Attorneys
4Viatris Inc.
Attorney Name: Arnold B. Calmann
Saiber
Viatris Inc.
Attorney Name: Jakob B. Halpern
Saiber
Viatris Inc.
Attorney Name: Monvan Hu
Saiber
Attorney Name: Albert Shih
Cause
15:1126 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09993467 | Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Jun 12, 2018 |
